Skip to main content
Medicare now covers breakthrough technology to treat uncontrolled high blood pressure

Decision means millions of Americans have access to the Medtronic Symplicity SpyralTM renal denervation system

Learn more

Press releases
Oct 28, 2025

Symplicity blood pressure procedure is now covered for qualifying Medicare patients GALWAY, Ireland, Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

Oct 26, 2025

Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the...

Oct 9, 2025

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first closed-loop DBS system for...

See more

In the news
Oct 29, 2025
Minnesota Star Tribune
Symplicity Spyral™ provides another option for patients who haven’t improved with medication, diet or exercise.
Oct 29, 2025
Axios Charlotte
In its first six weeks, IRCAD has held 27 courses and trained 932 health care providers. It's on track to train 8,000 professionals in the first year.
Oct 24, 2025
CBS News
Dr. Adam Arthur, chief medical officer for the neurovascular business at Medtronic, shares what patients should know about brain aneurysms and treatment.

See more

Sign up for the latest updates
* Required Fields